Resonate Health Revenue and Competitors

Auckland, NZL

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Resonate Health's estimated annual revenue is currently $7.7M per year.(i)
  • Resonate Health's estimated revenue per employee is $140,000

Employee Data

  • Resonate Health has 55 Employees.(i)
  • Resonate Health grew their employee count by 72% last year.

Resonate Health's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Head Sales & Customer ExperienceReveal Email/Phone
3
Head OperationsReveal Email/Phone
4
Head PartnershipsReveal Email/Phone
5
Clinical AudiologistReveal Email/Phone
6
NavigatorReveal Email/Phone
7
NavigatorReveal Email/Phone
8
Customer Experience SpecialistReveal Email/Phone
9
NavigatorReveal Email/Phone
10
NavigatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.7M5572%N/AN/A
Add Company

What Is Resonate Health?

We are all about ears and making you feel as comfortable about understanding your hearing health as you are about getting an eye test. Ear360 is a no-gimmicks assessment for everyone who wants to know how healthy their ears and hearing are. It’s a no strings attached, no hard sell assessment; designed to break down the stigma of hearing care and put you in control of your hearing health.\n\nFor those that do need hearing aids, we have reinvented the customer journey to offer Resonate Unlimited, a subscription model that offers only the very best technology at an affordable price. We are so confident in our service and our product that you can cancel your subscription at any time, no questions asked.\n\nResonate now sets the global benchmark for service, value and transparency in the hearing care industry.

keywords:N/A

N/A

Total Funding

55

Number of Employees

$7.7M

Revenue (est)

72%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.7M5531%N/A
#2
$12.1M5557%N/A
#3
$10.6M56-3%N/A
#4
$11.1M56-2%N/A
#5
$12.8M5633%N/A